Cadila Pharmaceuticals Ltd. Generic : Daunorubicin
360.00 20mg 1
â€¢ Skin :
Rash, skin inflammation and hives.
â€¢ Gastrointestinal : Nausea, vomiting, diarrhea and abdominal pain.
â€¢ Local : Cell death and painful induration.
â€¢ Miscellaneous : Fever, chills and rarely allergic reactions.
IV- Adult- The recommended dose is 60 â€“ 75mg/m2/day BSA (body surface area), every 3 weeks.
It comes as a solution for injection to be administered by a healthcare provider into the vein.
Contraindicated in patients with heart disease and hypersensitivity.
â€¢ Caution should be exercised in patients with heart, kidney or liver disease, bone marrow depression, gout, any allergy, who are taking other medications, children, during pregnancy and breastfeeding.
â€¢ Patient may develop with increased risk of heart disease (myocardial toxicity), bone marrow depression and secondary malignancy (cancer); if it is so consult with your doctor immediately.
â€¢ It may reduce platelet counts, which leads to bleeding; avoid injury or bruising.
â€¢ Monitor complete blood cell counts, heart, liver and kidney functions regularly while taking this medication.
â€¢ Avoid contact with people with infections.
Avoid drinking alcoholic beverages.
Avoid excess dosage.
Injection: Store it in refrigerator (2-8Â°C). Do not freeze.
Powder for injection: Store it at controlled room temperature (15-25Â°C).
Subscribe to our Free Newsletters!